Collaboration, genetic associations, and lupus erythematosus

New England Journal of Medicine

Volumn 358, Issue 9, 2008, Pages 956-961

  Crow, Mary K ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; AUTOANTIBODY; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CD11B ANTIGEN; ITGAM PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; EDITORIAL; GENE; GENETIC ASSOCIATION; HLA SYSTEM; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; INNATE IMMUNITY; ITGAM GENE; LUPUS ERYTHEMATOSUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; GENOTYPE; IMMUNOLOGY; NOTE; PHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD11B; AUTOANTIBODIES; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SRC-FAMILY KINASES;

EID: 40049099006     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0800096     Document Type: Editorial

References (22)

1. Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008;358:900-9.
2. International Consortium for Systemic Lupus Erythematosus Genetics, Harley JB, Alarcon-Riquelme ME, et al. A genomewide association scan in women with systemic lupus erythematosus identifies risk variants in ITGAM, PXK, KIAA1542 and other loci and confirms multiple loci contributing to disease susceptibility. Nat Genet (in press).
3. Kozyrev SV, Abelson A-K, Wojcik J, et al. Functional variants in the B cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet (in press).
4. Nath SK, Han S, Kim-Howard X, et al. A non-synonymous functional variant in integrin-α-M (ITGAM) is associated with systemic lupus erythematosus. Nat Genet (in press).
5. Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006;54:408-20.
6. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007;8:492-502.
7. Sigurdsson S, Göring HH, Kristjansdottir G, et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 reveals a novel 5bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet (in press).
8. Graham RR, Ortmann W, Rodine P, et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007;15:823-30.
9. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-9.
10. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007;179:4704-10.
11. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
12. Aoki Y, Kim YT, Stillwell R, Kim TJ, Pillai S. The SH2 domains of Src family kinases associate with Syk. J Biol Chem 1995;270:15658-63.
13. Tretter T, Ross AE, Dordai DI, Desiderio S. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J Exp Med 2003;198:1863-73.
14. Yokoyama K, Su Ih IH, Tezuka T, et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phophorylation of IP(3) receptor. EMBO J 2002;21:83-92.
15. Aiba Y, Yamazaki T, Okada T, et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 2006;24:259-68.
16. Salmon JE, Millard S, Schacter LA, et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996;97:1348-54.
17. Wang Y, Sakuma M, Chen Z, et al. Leukocyte engagement of platelet glycoprotein Ibalpha via the intergrin Mac-1 is critical for the biological response to vascular injury. Circulation 2005;112:2993-3000.
18. Sotiriou SN, Orlova VV, Al-Fakhri N, et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J 2006;20:559-61.
19. Buyon JP, Shadick N, Berkman R, et al. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988;46:141-9.
20. Belmont HM, Abramson SB. Mechanisms of acute inflammation and vascular injury in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:236-54.
21. Lee-Kirsch MA, Gong M, Chowdhury D, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007;39:1065-7.
22. Richards A, van den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007;39:1068-70.